The Central Nervous System (CNS) Therapeutics Market is witnessing strong growth, driven by the rising prevalence of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, epilepsy, depression, and multiple sclerosis.

https://m2squareconsultancy.co....m/reports/cns-therap